Translocations resulting in over‐expression of cyclin D1, t(11;14), are associated with standard risk in MM whereas those leading to over‐expression of cyclin D2 such as t(4;14) and t(14;16) are associated with higher risk disease. This evidence concerns the gene CCND1 and Miyoshi myopathy.